Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Hartl (Wien, Austria). Blood eosinophils and obstructive lung diseases – results from the population-based Austrian LEAD Study. 2631

Member's Comments

No comment yet.

Related content which might interest you: Association between chronic obstructive pulmonary disease and endometriosis: a population-based cohort study Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases Year: 2020 Blood eosinophils and obstructive lung disease in the general population Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Treatment outcome among post TB obstructive airways diseases & COPD: A Prospective Cohort study Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Interstitial lung diseases in children: The French national cohort study Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Radon and COPD mortality in the American Cancer Society Cohort Source: Eur Respir J 2012; 39: 1113-1119 Year: 2012 LATE-BREAKING ABSTRACT: Blood eosinophils and exacerbations in chronic obstructive pulmonary disease: The copenhagen general population study Source: International Congress 2015 – New observations in respiratory epidemiology Year: 2015 The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol Source: Eur Respir J 2013; 41: 1017-1022 Year: 2013 Risk factors for idiopathic pulmonary fibrosis in Southern Europe: A case-control study Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis Year: 2013 The population risk attribution associated with chronic airway obstruction from the results of the Canadian Obstructive Lung Disease study. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Subclinical cardiovascular disease in early emphysema. The MESA Lung Study Source: Annual Congress 2008 - Outcome and trends in obstructive lung disease (OLD) and cardiovascular relation to OLD Year: 2008 Clinical trials for elderly patients with multiple diseases (CHROMED): A pilot study Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Symptoms of chronic bronchitis are associated with lower heart rate variability - SAPALDIA 2 - Swiss Cohort Study on Air Pollution and Lung diseases in Adults Source: Eur Respir J 2005; 26: Suppl. 49, 120s Year: 2005 Respiratory function and the risk of lung cancer in COPD patients: A population-based cohort study Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016 COPD in non-smokers: Report from the Tunisian burden of obstructive lung disease study Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 CPOD and lung function parameters as predictors of mortality: Results from the Latin American PLATINO cohort study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Clinical presentation and outcomes of venous thrombo-embolic diseases in chronic obstructive pulmonary diseases. Findings from the RIETE Registry Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010 Sarcoidosis in the UK: Insights from the BTS interstitial lung disease registry Source: International Congress 2016 – Sarcoidosis Year: 2016 Severe asthma registry from the Institute for pulmonary diseases of Vojvodina: Baseline characteristics Source: International Congress 2019 – Clinical approach to asthma management Year: 2019